SLC6A3 and Parkinson disease: There is evidence, in animal models of PD, that lesioning dopaminergic neurons causes reduced DAT-BPND values, increased D2 receptor binding, and increased BOLD response to apomorphine in the striatum (Nguyen et al. 2000).